Reddit Posts
$ENSC just broke down trend. News Oct. 19th, 2.7 mil float, price target $9-$18
$ENSC down 50% from its pop yesterday! Needs Volume to run again!
High Risk ENSC Stock: Buyers Crowdout Sellers. Final Stage Of The Phase ...
ENSC starting to take off - 600% CTB 100K available to short, float 4.61
ENSC - Ensysce Biosciences Announces Data from PF614-MPAR-101-Part A Successfully Demonstrating Opioid Overdose Protection
ENSC opioid drug for addiction overdose pain. recent rs. last week pos results in trial it moved from to about 1.20 under 2 Mill shares float. fintel has it shorted 17% and off exchange of 50%. small float high si already did rs positive news from trial. public offering at 1.40. 2$ if gets attention
$ENSC 707% Short Fee & only 25k shares left Ultra low float -DD
$ENSC, $DAKT, $BRQS, $IBIO- Down big ....on big volume
$ENSC insane ortex 👀 anyone in this play already?
💰💰💰Good morning! #premarket #watchlist 11/21 $WETG -Announces US$120 Million Agreement with Vmade Tech PTE. LTD, $COSM -to Sell its Sky Premium Life Luxury Food Supplement Brand on Iberian Airlines, $ENSC -earnings
How to get off from stock split stock?
ENSC some DD and personal opinion which will be in comments
TBLT just reported 76% increase in sales, .05 EPS and $28.5 in working capital - MASSIVE (millions) FTDS, 6% short
ENSC. Tiny float after R/S and just jumped from 900 watchers to 7000+ on ST. Has great tech to combat the opioid crisis! NFA.
Cheap Nasdaq Stocks Moving Up Today---
Been eyeing $ENSC for months, this gonna be the next runner in the coming week. 🚀 🌙 🚀 🌝 🚀 🌙 🚀 🌝 🚀 🚀 🚀
$ENSC undervalued and rock bottom opioid play - sunday bad DD
ENSC vs TTOO… May the Best stock win!
ENSC - Projected to reach $10 in upcoming months. The stock is at the very bottom and funded from NIDA so they seem rock solid, They have a corporate call shortly and it’s going up and up, jump in so you don’t miss on this. Got myself a good coverage as well!
ENSC REVERSE STOCK SPLIT COMING? just got this in mail
ENSC Bioequivalence results due by next week and another trial with results expected in September..it has already put out invites to begin partnership
In your opinion, what is the best pennystock to buy that is currently priced between $0.25c - $0.75?
I called out $REVB, now it’s time for $ENSC to run up 100%. Mark my words.
ENSC waiting for results this quarter.. it could replace much of oxycontin prescriptions.. what you think about 🤔
VOLUME 🚨 100M volume can literally squeeze $ENSC a minimum of 200%‼️‼️‼️ Float 14M with 29M shares outstanding 🤯 Currently $1 with price targets up to $23 🚀🚀🚀 Reported 12.3M cash ending 2021 compared to 0.2M ending 2020. Trial results coming out Q2 with enough cash until 2023 so no offerings 😎
LETS SQUEEZEEEEE $ENSC 😎 Super low float!!!
High CI plays for Next Week (4/18-4/22)
ENSC loaded before results in Q2.. it could be the next SBFM
ENSC volume increasing probably results incoming.. 💣🚀
ENSC could be the next SBFM.. results in Q2 with a very low float
ENSC. Solid pipelines, large recent inflow
someone that has ENSC ortex data ...
Anyone looking at $ENSC. Going to boost today on good news. Could easily see above $2
ENSC!!! STATE OF THE UNION OPIOIDS Crisis
ENSC needs a little push, ready to fly!
ENSC. Ok this is fkn insane. Is this for real?
ENSC is squeezing!! Get in now and buckle up 🚀🚀🚀
ENSC is squeezing! Get in not and buckle up 🚀🚀🚀🚀🚀
sighh ENSC covering, it kills the shortsqueeze
Top 25 Short Squeeze Stocks - January 3, 2022: SYTA, AVCT, ENSC, SDC, IINN
Fintel's #ShortSqueeze Screener and Leaderboard for all you thirsty Short Squeezers. $ISIG $PTPI $AVCT $SEAC $IINN $SPRB $STRN $ENSC
ENSC CTB MAX 394.84% Same insane cost to borrow like AVCT..
$ENSC has very high CTB and is going to fly. Short Squeeze Score 96%
$ENSC might only be steps away from squeezing up
Daily Squeeze Data: December 29, 2021 - $ISIG, $PTPI, $ENSC, $LMND
Daily Squeeze Data: December 29, 2021 - $ISIG, $PTPI, $ENSC, $LMND
One big reason to have diaomond hands for ENSC! ANSON funds Under investigation by the DOJ
AVCT - From 147K shares shorted to 4.71M in 4 weeks. Per Nasdaq
ENSC - Is primed to run more than you all realize Lets take a look at the DD
ENSC ranked for "Strong Buy" Candidate on Stockinvest (a rare feat)
$ENSC - Literally flying under the Radar, and with Good Data; Final Updated DD.
ENSC ready for $8 after hours! Load up now!
Here’s your chance for entry in ENSC!
$ENSC - Literally flying under the Radar, and with Good Data
ENSC small float bio seeking to address pain management
ENSC Stock Relentlessly Defying Sellers. How High Can It Go?
How did we miss ENSC lol?! This thing is shorted to oblivion…the borrow fee is at 200% look like it just started to squeeze , I slapped 20 bucks on it for the hell of it 😂
ENSC - It looks like the Shorts have reached their limit.
Just solidly asking : who think about ENSC to be good forward, like last week ? I'm in yet , and think it will get back near it's earlier price soon (~10$ ) ...
ENSC with enough support, could be easily get a 7-8$ PT ...
ENSC buyers at the gate, who will assist them to get into the castle ? I'm in ... Shortsqueeze for this stock ? What do you think guys ?
ENSC can be huge next week and this is why. Serious shit. Trapped more shorts today, given a PT of $23 and many gaps to fill this can fly. 👀💰💰 Who's in?
ENSC can be huge next week and this is why 👀💰 Given a PT of $23 and gaps to fill it will be huge!
ENSC can be huge next week and this is why 👀🔥
ENSC better go up for your sakes for I will release an unspeakable ruthless rampage over this chat if it doesnt
Does anyone have ENSC short interest and other data? Lot of buying pressure just before close, this can run again with this $23 price target! (Currently $4.4)
Looks like ENSC is setting up another nice trend. 🚀
Who think ENSC became a hero runner-up forward from this, starting on monday ? AH today will be interesting or just usual ? Thoughts ?
Mentions
Premarket Watchlist **$LBGJ** : Round two? **$ENSC** : Micro Bio **$ORIS** : Needs volume :flag_cn: **$CMCT** : Continuation if volume **$IOBT** : 3/30 Earnings ( @mamegan. ) **$MDAI** : https://finviz.com/news/338447/spectral-ai-awarded-317-million-of-barda-funding-to-accelerate-development-of-the-deepview-system
I found some stocks of ENSC in the dungeons. I see a crazy analyst showing TP of $25 up from 0.5. Is anyone in the same Titanic with me?
Check out ENSC and BHAT
Why ENSC? Theyre losing 4x theit market cap every yr. Just trying to understand...
ENSC ONMD for power hour
ENSC starting another potential run with everyone back from lunch
She’s still playing. ENSC is an opioid pay. Anything with addictions will be big in a recession.
ENSC LFG! Opioids are always sexy!
AURI (OTC) is good profit if it runs on acquisition news. ENSC and BOTC i am not seeing any press release but major volume so that's a good ground for me. Also keeping an eye on MRM.
ENSC moving up slowly
Target price for ENSC?
ENSC .60-.66. 7% in two minutes. Full ported. Over and out on the day. A full week of straight wins. Cheers everyone I’m taking off.
ENSC 35 million volume so far on a float of 3.6 million. Only one with the volume as of now. Watching for a test around .57 and looking for bulls to take over. Then I might hop in. No moves yet. Do your own research.
ENSC only one im watching currently. No moves yet. Watching 15 and 5 charts on this one. Anyone else seeing this one?
Earlier I gave a good entry for a scalp at around 0.465 for ENSC and got mansplaned about how 'sh!ts tanking'. I just exited at 0.535. On a morning like this one, that's a nice scalp. There have been a few moments like this over the past month, and I'm pretty some of them have chipped into my profits. Just saying.
ENSC moving! Thanks, Jasmine!
ENSC already running nicely from last night, I think it will do very well today.
ENSC is the next Bio to pop!
ENSC likely to be a thing tomorrow PM
ENSC just went down the toilet my goodness
Is ENSC a better buy now? Lol
ENSC HOD so far, looking for 60c
I’m in ensc and SRXH rn , 100k ENSC (.4936) and 500k SRXH (.1425)
ENSC…I didn’t see the massive drop but I would buy this dip due to the volume
This one was very safe. I didn't trust ENSC nor AEHL.
Is $ENSC a short bus level hold?
ENSC The price drops further, I buy more. 1.66% of all shares so far.
i'm convinced that biotech alone are responsible for the saying that 95% of investors sell just before they hit a massive win. and the ones that don't sell, like me with CABA, double down on the same regarded mythology, like me with ENSC.
ENSC anybody? Just secured FDA breakthrough!
Anyone jumping on ENSC? They just received positive feedback from the FDA. Any thoughts?
$ENSC Ensysce Biosciences Q1 EPS $(1.39) Beats $(3.02) Estimate, Sales $1.32M Up From $305.72K YoY
$ENSC Ensysce Biosciences Q1 EPS $(1.39) Beats $(3.02) Estimate, Sales $1.32M Up From $305.72K YoY
$ENSC Ensysce Biosciences Q1 EPS $(1.39) Beats $(3.02) Estimate, Sales $1.32M Up From $305.72K YoY
ENSC making a come back GFAI going up earnings on Monday
Do stocks even start to explode during market open? For a while, I noticed that they start either during PM or AH (e.g. ENSC earlier) and their behavior at the start of open market really make me nervous
ENSC looking like a lovely reversal play
ENSC - Before it's too late [https://www.barchart.com/story/news/32006942/ensysce-biosciences-receives-us-patent-for-groundbreaking-treatment-of-opioid-use-disorder](https://www.barchart.com/story/news/32006942/ensysce-biosciences-receives-us-patent-for-groundbreaking-treatment-of-opioid-use-disorder)
mmm ENSC is very tempting, but I have to wait till market open . Guys what do you think? It is still worthwhile a gamble? Or now it is too late and the party will be over soonish?
ENSC shoutout Beaver pelt for leading me to play Pro Ticker choices
So my pharma play yesterday ENSC spent most of AH/PM/today just slowly losing value. Do y'all think the same will happen for BCTX and MIRA? holding some bags there from PM today when they seemed promising (and I bought in high)...
Anyone holding bags of ENSC? I saw the low float after someone shouted it out ... but I'm curious if anyone thinks it's going to go back up. PM has been a slow bleed.
Anyone got some speculation on ENSC? I was hearing about low float and good news, but nothing really else apart from that.
Boring day for those of us not on the SUNE train... but yeah ENSC looks promising
ENSC is starting to heat up if anyone's out of SUNE
ENSC and SUNE looking good
https://www.stocktitan.net/news/ENSC/ensysce-biosciences-announces-positive-data-from-opioid-overdose-69ir17v7mbhe.html “Only opioid product with FDA's Breakthrough Therapy designation” Gonna put a bit in ENSC. Pretty good news with a tiny float
Yessir! I cannot tell you which ones, I’ve probably played at least 100 in the past 2 months. Recent memory: FOXO RGTI IDAI OPTT JXAI ENSC JFBR
- BFLY : digital health company focused on providing portable, semiconductor ultrasound units - BCTX: cancer immunotherapy with one in Phase 3, FDA fast tracked and beating current therapies for breast cancer. Way undervalued, in my opinion - ENSC: Potential solution for pain other than opioids
Ensysce Biosciences, Inc. (ENSC) is currently experiencing heightened speculative interest, with potential short squeeze activity driving recent price volatility. The stock has seen a significant increase in volume and price, moving from $0.33 to $0.84 over the past month, indicating strong buying pressure possibly linked to short covering. Technical indicators show bullish momentum, with the current price well above the 10-day SMA of $0.49 and the MACD histogram positive, suggesting continued upward movement. However, the RSI near 60 indicates the stock is approaching overbought territory, warranting caution. Given the broader market’s bullish sentiment, ENSC could see further gains if momentum persists. For today’s session, consider a long position with an entry around $0.82, targeting $0.95 as the first target and $1.05 as the second, with a stop loss at $0.75. Confidence in reaching the first target is moderate due to current momentum, but the second target carries higher risk given potential volatility and lack of fundamental catalysts.
Hedge Fund just bought 10% of ENSC bio last night. Here comes the next DRUG. Get on the bandwagon. $.60 > $10 this week. Easy money.
Here we go y’all. A hedge fund just came in and bought 9% of ENSC yesterday. Be prepared For the ride up! Give the post some ups so others can help the volume and awareness. This is going to be like DRUG and get up to $10-&12 at the lowest.
ENSC is my favorite that I watch closely. I don’t have any other suggestions :-( It should hit .80 a .90 tomorrow early and then drop back down.
I got a feeling ENSC is gonna hit the moon tomorrow or sometime this week. Medical stocks have been HOT since last week. Biotechs, biopharms, gene therapies, etc…
EOSE: Eos Energy Enterprises, Inc. (EOSE) is currently trading at $3.12, showing a consolidation pattern after a recent rally from the $2.50 level. The 10-day SMA at $3.18 and the 8-day EMA at $3.19 suggest a short-term resistance, while the RSI levels indicate neutral momentum, providing room for potential upside. The MACD histogram is slightly negative, hinting at a possible pullback, but the broader market's cautious optimism and strength in technology sectors could support EOSE's upward movement. Given the lack of significant news, technical indicators will likely drive today's action. I recommend entering a long position around $3.10, with a first price target of $3.25 (moderate confidence) and a second target of $3.35 (lower confidence), setting a stop loss at $3.00 to manage downside risk. This strategy aligns with the current market sentiment and EOSE's technical setup, offering a balanced risk-reward profile for day traders. ENSC: Ensysce Biosciences, Inc. (ENSC) is experiencing significant momentum, with a current price of $0.505 and a recent surge in volume, indicating strong buying interest. The RSI levels are extremely overbought, suggesting potential for a pullback, but the MACD histogram shows bullish momentum. The stock has broken past its 30-day SMA of $0.2609, signaling a strong upward trend. Given the broader market's cautious optimism, ENSC could benefit from continued interest in growth sectors. For today's session, consider entering around $0.50, with a first target at $0.55 and a second target at $0.60, while setting a stop loss at $0.45 to manage risk. Confidence in reaching the first target is high due to recent volume spikes and technical breakouts, while the second target carries moderate confidence given potential volatility. Keep an eye on any sudden shifts in market sentiment or unexpected news that could impact this micro-cap stock. HUMA: Humacyte, Inc. (HUMA) is facing significant headwinds due to an ongoing investigation into potential federal securities law violations, which has already impacted its FDA application and manufacturing capabilities. The stock's technical indicators show a mixed picture: the MACD histogram is slightly positive, suggesting weak bullish momentum, while the RSI hovers around neutral, indicating indecision. Recent trading volumes have been erratic, with a notable spike in volatility, reflecting investor uncertainty. Given the broader market's cautious optimism, HUMA may not align with the tech-driven strength seen in indices like QQQ. For today's session, expect potential downside pressure; consider entering a short position around $5.50. Set a first price target at $5.30 and a second at $5.10, with a stop loss at $5.60 to manage risk. Confidence in these targets is moderate due to the unpredictable nature of legal investigations and their impact on stock sentiment. RILY: B. Riley Financial, Inc. (RILY) is showing signs of bullish momentum, with the current price at $5.98, above key moving averages (10-day SMA at $5.31 and 8-day EMA at $5.64), indicating a potential continuation of the upward trend. The MACD histogram is positive, suggesting increasing buying pressure, while the RSI levels are approaching overbought territory, which could signal a short-term pullback. Given the broader market's cautious optimism, RILY may benefit from the strength in growth-oriented sectors. For today's session, consider entering a long position around $5.95, with a first price target of $6.30 and a second target of $6.50, supported by recent highs. Set a stop loss at $5.75 to manage downside risk. Confidence in reaching the first target is moderate due to strong technical indicators, while the second target carries lower confidence given potential market volatility. Keep an eye on volume spikes as they could confirm the breakout.
$ENSC has 750 Million shares traded today. Def a pump and dump but I've never seen volume that high, ever.
ENSC, okay we see you 
ENSC - Ensysce Biosciences It used to be worth alot now its a penny stock. This could end up being a 1000%+ if pumped as it has very low market cap right now and low daily trade volume under 100k so if it gets noticed and people pump the stock it could go insanely high if you look at what it used to he priced at
Green for the next week will be ENSC and CDZI ya heard these are moving with not that much volume but still enough for liquidity. If either of these trade over 1m shares they will be +40% easy
Ensysce BioSciences or Nasdaq: ENSC
ENSC hawt chick at the prom ill ride it
ENSC has is super low float and has potential to hit $2. Im so ready for this ticker
Ah ENSC….back from the depths of hell haha
ENSC potential 50 bagger in two years. TCON potential 5 bagger in 3 weeks Place your bets
YES! When you can help end the Opiate Epidemic w/ $ENSC... Rock bottom price, second leg of a double bottom on a 5 year chart. Nearly the same price & FDA approval will be by March 24th...
ASLN, NKGN, GRI, TPET, TCBP, RVSN, VLD, YOSH, ENSC, and just maybe FSR. look into it my G
currently looking into ENSC & NKGN, have not made a decision yet. Primary drive is #TCBPTakeOff 🧬🌙 just bought even more shares about an hour ago 🦠🔬
Get in ENSC . 50X incoming. No worries about squeezing
You want a 50 bagger??? ENSC and thank me after a year
Hot Stock To Check Out- FDA Breakthrough Therapy Heading to Phase III I did some research - please take a look as this could explode over the next year!! https://ensysce.com/ Ensysce Bioscience- ENSC is the stock ticker Think about it folks so many Bio Pharma claim to have a cure for cancer. ENSC has a niche to help/solve the Opioid Crisis that gets worse every day. Basically they have something that no one else has- niche market and FDA approval happens the price will skyrocket! $ENSC The impact of the Breakthrough Therapy Designation from the viewpoint of large pharmaceutical companies: Big companies know what the FDA thinks of this treatment: "A breakthrough therapy designation is for a drug that treats a serious or life-threatening condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement on a clinically significant endpoint(s) over available therapies." 2. Average approval time reduced by 2.5-3.5 years. 3. Less money is required- possible to reduce 50% of overall development cost. Patnership/buyout is almost guaranteed and that’s when the big payoff will come… $ENSC Another collaboration with a company developing another pain product entirely different from opioids to treat oral mucositis in patients with cancer, people who are undergoing radiation or chemotherapy, and alterations in the mouth. This product is being evaluated in Europe and ENSC has become the American arm of the company developing it. They working with them to try and get it on the market here to help people with cancer alleviate their pain as well. This is their partners website - https://oncozenge.se
Hot Stock To Check Out- FDA Breakthrough Therapy Heading to Phase III I did some research - please take a look as this could explode over the next year!! https://ensysce.com/ Ensysce Bioscience- ENSC is the stock ticker Think about it folks so many Bio Pharma claim to have a cure for cancer. ENSC has a niche to help/solve the Opioid Crisis that gets worse every day. Basically they have something that no one else has- niche market and FDA approval happens the price will skyrocket! $ENSC The impact of the Breakthrough Therapy Designation from the viewpoint of large pharmaceutical companies: Big companies know what the FDA thinks of this treatment: "A breakthrough therapy designation is for a drug that treats a serious or life-threatening condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement on a clinically significant endpoint(s) over available therapies." 2. Average approval time reduced by 2.5-3.5 years. 3. Less money is required- possible to reduce 50% of overall development cost. Patnership/buyout is almost guaranteed and that’s when the big payoff will come… $ENSC Another collaboration with a company developing another pain product entirely different from opioids to treat oral mucositis in patients with cancer, people who are undergoing radiation or chemotherapy, and alterations in the mouth. This product is being evaluated in Europe and ENSC has become the American arm of the company developing it. They working with them to try and get it on the market here to help people with cancer alleviate their pain as well. This is their partners website - https://oncozenge.se
Hot Stock To Check Out- FDA Breakthrough Therapy Heading to Phase III I did some research - please take a look as this could explode over the next year!! https://ensysce.com/ Ensysce Bioscience- ENSC is the stock ticker Think about it folks so many Bio Pharma claim to have a cure for cancer. ENSC has a niche to help/solve the Opioid Crisis that gets worse every day. Basically they have something that no one else has- niche market and FDA approval happens the price will skyrocket! $ENSC The impact of the Breakthrough Therapy Designation from the viewpoint of large pharmaceutical companies: Big companies know what the FDA thinks of this treatment: "A breakthrough therapy designation is for a drug that treats a serious or life-threatening condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement on a clinically significant endpoint(s) over available therapies." 2. Average approval time reduced by 2.5-3.5 years. 3. Less money is required- possible to reduce 50% of overall development cost. Patnership/buyout is almost guaranteed and that’s when the big payoff will come… $ENSC Another collaboration with a company developing another pain product entirely different from opioids to treat oral mucositis in patients with cancer, people who are undergoing radiation or chemotherapy, and alterations in the mouth. This product is being evaluated in Europe and ENSC has become the American arm of the company developing it. They working with them to try and get it on the market here to help people with cancer alleviate their pain as well. This is their partners website - https://oncozenge.se